Hence, we could not only demonstrate that Mcl1 expression is elevated in primary and metastatic tumors which confirms previous observations by Krajewska et al. and Zhang et al. [43, 44], but were also able to demonstrate that its expression, similar to that of PIAS1, is further induced after docetaxel chemotherapy and in resistant cells. Here, MCL1 is linked to metastatic neoplasm.